Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-047189
Filing Date
2021-07-19
Accepted
2021-07-19 16:58:50
Documents
2
Period of Report
2021-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5142
2 POA DOCUMENT poa.txt EX-24.3_999558 3818
  Complete submission text file 0001209191-21-047189.txt   10289
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Issuer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HCW BIOLOGICS, INC. 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address
Jiao Jin-an (Reporting) CIK: 0001866271 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40591 | Film No.: 211098475